(redirected from hormone replacement therapy)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
See: treatment
References in periodicals archive ?
Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
until Willett's team excluded women who take hormone replacement therapy.
However, researchers caution that the link between the change in breast density as a result of hormone replacement therapy and the change in a woman's risk of developing breast cancer remains uncertain.
The patient's postoperative course was unremarkable, and he was discharged on hormone replacement therapy.
Thirty-two percent of women with cancer and 35% of controls had ever used oral contraceptives, while 26% and 21%, respectively, had ever used hormone replacement therapy (estrogen with or without progestin).
With the finding, the National Institutes of Health (NIH) stopped a trial of women taking hormone replacement therapy using the combination of estrogen and progestin.
At the start of the study, 40% were using some form of hormone replacement therapy (HRT), and 28% used HRT throughout the study.
Hormone replacement therapy (HRT) involves taking the two main female hormones - oestrogen and progesterone - to combat menopause problems.
Hormone replacement therapy has been associated with a higher than normal incidence of breast or uterine cancer because of the tumour-triggering effects of oestrogen.
Materials cover such topics as: how to stop smoking, high blood cholesterol, high blood pressure, physical activity, heart-healthy recipes, hormone replacement therapy, coronary heart disease, heart failure, and heart arrhythmias.
This treatment, called hormone replacement therapy (HRT), can ease symptoms of menopause and protect against risks of heart disease, stroke, and osteoporosis.
com/research/8eedc9/postmenopausal_ho) has announced the addition of GlobalData's new report "Post-Menopausal Hormone Replacement Therapy (HRT) - Pipeline Assessment and Market Forecasts to 2018" to their offering.